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Background: MicroRNAs play important roles in regulating biological processes, including organ morphogenesis
and maturation. However, little is known about specific pathways regulated by miRNA during lung development.
Between the canalicular and saccular stages of the developing lung several important cellular events occur,
including the onset of surfactant synthesis, microvascular remodeling and structural preparation for subsequent
alveolarization. The miRNAs that are actively regulated, and the identity of their targets during this important
developmental interval in the lung remain elusive.
Results: Using TLDA low density real-time PCR arrays, the expression of 376 miRNAs in male and female fetal
mouse lungs of gestational days E15 – E18 were profiled. Statistical analyses identified 25 and 37 miRNAs that
changed significantly between sexes and with gestation, respectively. In silico analysis using Ingenuity Pathway
Analysis (IPA) identified specific pathways and networks known to be targets of these miRNAs which are important
to lung development. Pathways that are targeted by sex regulated miRNAs include retinoin, IGFR1, Tp53 and Akt.
Pathways targeted by gestation-regulated miRNAs include VEGFA and mediators of glucose metabolism.
Conclusion: MiRNAs are differentially regulated across time and between sexes during the canalicular and saccular
stages of lung development. Sex-associated differential miRNA expression may regulate the differences in structural
and functional male and female lung development, as shown by networks generated using in silico analysis. These
data provide a valuable resource to further enhance the understanding of miRNA control of lung development and
maturation.
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It is clear that miRNAs regulate numerous important devel-
opmental processes in various organs. miRNAs are a class
of small RNAs that post-transcriptionally regulate gene ex-
pression. The primary RNA (pri-miRNA) is transcribed
from the genome and is processed by Drosha, an RNase III
enzyme, into hairpin structured premature miRNAs (pre-
miRNAs). These pre-miRNAs are exported out of the nu-
cleus with the help of Exportin 5, and cleaved into double
stranded duplexes by Dicer, another RNase III enzyme. The
mature miRNAs are loaded onto nucleoprotein complexes* Correspondence: Heber.nielsen@tufts.edu
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reproduction in any medium, provided the orcalled the RNA-induced silencing complex (RISC). The
mature miRNAs in these complexes inhibit translation of
target mRNAs by blocking translation or aiding in degrad-
ation of their targets [1].
An important role of miRNAs during lung morpho-
genesis has been recently established. Conditional dele-
tion of Dicer from the lung epithelium led to arrested
airway branching, dramatically altering lung organogen-
esis [2]. Subsequent studies of miRNA profile expression
in the lung demonstrated that miRNAs are temporally
expressed between the embryonic and adult lung devel-
opment [3-7].
Mouse lung development is divided into five stages:
embryonic (E9.5-E11.5), pseudoglandular (E11.5-16.5),
canalicular (E16.5-E17.5), saccular (E17.5-P5) and alveolar
(post-natal (P)5-P30). The coordination of multiple path-
ways across various cellular compartments is required to
give rise to a fully developed lung. The transition from thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Mujahid et al. BMC Developmental Biology 2013, 13:13 Page 2 of 11
http://www.biomedcentral.com/1471-213X/13/13late canalicular to early saccular stage is a crucial period in
preparation for survival after birth. During the canalicular
stage establishment of the air-blood barrier begins and
epithelial differentiation of alveolar Type I and Type II
cells commences. The onset of surfactant synthesis plus
microvascular development in the early saccular stage are
necessary for proper lung function at birth. The timing
and coordination of genetic- and sex - specific program-
ming that occurs during these lung developmental stages
are crucial regulatory elements for lung maturation [8].
Very little is known about how miRNA expression and
genetic control contributes to these critical events. The re-
cent evidence showing the importance of miRNAs in de-
velopment and disease of other organs indicates the need
for more detailed studies of how miRNAs regulate path-
ways important in the developing lung [9].
The aim of this study was to analyze the dynamic
regulation of miRNAs during the canalicular to early
saccular stage of mouse lung development. We profiled
miRNAs of lungs isolated from male and female E15-
E18 fetal mouse lungs. It is well established that male
infants have increased perinatal respiratory morbidity
and mortality and that androgens inhibit lung matur-
ation in males [10,11]. In mouse lung development, the
development of surfactant production during this cana-
licular to early saccular interval is delayed by one day in
males compared to females [12]. Several important tran-
scription factors and signaling pathways are differen-
tially expressed and activated in males and females
during this time, suggesting that it is very likely that
miRNAs may also be regulating these sex differences as
well [13,14].
In this study, we show that a group of miRNAs are
differentially expressed across these gestational ages, and
another group of miRNAs differentially expressed be-
tween males and females. These groups were further
analyzed for pathway interactions using Ingenuity Path-
way Analysis, which maps interactive pathway networks
based on established miRNA targets previously reported
in the literature. With the IPA analysis we are able to
highlight pathways regulated by these developmentally
regulated miRNA groups that are differentially expressed
across gestation, and between males and females, during
an important window in lung development.
Methods
The animal study protocol was approved by the Tufts
Medical Center Institutional Animal Care and Use Com-
mittee. Principals of laboratory animal care were followed
according to the National Institute of Health Guidelines
for Care and Use of Laboratory Animals. Timed pregnant
Swiss Webster mice were obtained from Charles River La-
boratories (Wilmington, MA, USA), with the morning of
the vaginal plug defined as gestational day 0 (E0).Isolation of total RNA
Timed pregnant mice at each gestational age were
sacrificed using CO2 inhalation according to the approved
protocol and in line with current regulations. The uterus
was removed under sterile conditions by laparotomy and
placed on ice. Fetuses were maintained in DMEM on ice
while fetal sex was identified [15]. The lungs were removed
en block under a sterile laminar airflow hood. Lungs were
frozen for RNA extraction. RNA was extracted using
miRVana miRNA Isolation Kit (Ambion, Grand Island,
NY) according to the manufacturer’s instructions.
miRNA arrays
A Taqman Array Rodent MicroRNA A card v2.0 (Ap-
plied Biosystems, Carlsbad, CA) was used to profile 376
mature miRNAs. cDNA was transcribed from total RNA
using the Megaplex TM RT Rodent Primers Pool and
the TaqMan MicroRNA Reverse Transcription Kit. The
TaqMan miRNA Arrays were run on the ABI PRISM
7900 System using the TaqMan Universal PCR Master
Mix according to the manufacturer’s instructions. Two
array runs using separate lungs with two technical repli-
cates per lung were performed. The data from these runs
were used in the data analysis model. The delta CT was
calculated by subtracting the miRNA Ct value from the Ct
value of small nuclear U6 RNA, which served as a control.
The data were normalized to E15 for data analysis. The
data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus and are accessible
through GEO Series accession number GSE46037 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46037).
Data analysis
For each miRNA, we separately evaluated the effect of
gestation (time) and gender (sex), and then tested if the
temporal patterns differed between males and females.
We used mixed linear models with fixed main time and
sex effects, their interaction effect, and random sample
effect to account for any correlated nature of the data.
The analyses were performed using base, nlme, and
qvalue packages of statistical software R [16-18].
Cluster analysis for the miRNAs that changed signifi-
cantly across gestation and with fetal sex was done using
gplots package of statistical R software [19]. Ingenuity
Pathway Analysis (IPA) was used to generate pathways
regulated by these miRNAs based on validated miRNA
targets (Ingenuity Systems, www.ingenuity.com, August
2011 version).
Results
Specific miRNAs are differentially expressed between
sexes and with advancing gestation
MiRNA profiles from E15-E18 male and female mouse
lungs were generated using a miRNA qPCR array
Table 1 miRNAs that changed significantly with sex and gestation
miRNA gene P-value Chromosome Chromosomal location miRNA family miRNA cluster
Sex
mmu-miR-802 0.025 16 intergenic mir-802
mmu-miR-138 0.047 9,8 intergenic mir-138
mmu-miR-182 0.026 6 intergenic mir-182
mmu-miR-296-3p 0.034 2 intergenic mir-296 1
mmu-miR-125a-5p 0.037 17 exon mir-125 2
mmu-miR-532-3p 0.002 X intron mir-188 3
mmu-miR-652 0.04 X intron mir-652
mmu-miR-455 0.01 4 intron mir-455
Y1 0.002 * * *
mmu-miR-670 0.016 2 intron, exon mir-670
mmu-miR-367 0.008 3 intron mir-367 4
rno-miR-207 0.013 5 intron mir-207
mmu-miR-31 0.001 4 intergenic mir-31
rno-miR-351 0.018 X intergenic mir-351
mmu-miR-351 0.009 X intergenic mir-351
mmu-miR-220 0.013 * * *
mmu-miR-219 0.015 17,2 exon, intergenic mir-219
mmu-miR-24 0.013 13,8 intron, exon mir-24
mmu-miR-141 0.04 6 intron mir-8
rno-miR-743b 0.006 X intergenic mir-743 3
mmu-miR-470 0.005 X intergenic mir-743 1
mmu-miR-615-3p 0.001 15 intron mir-615
rno-miR-327 0.002 * * mir-327
mmu-miR-742 0.002 X intergenic mir-742 4
mmu-miR-486 0.035 8 intron mir-486 1
Gestation
mmu-miR-452 0.011 X intron mir-452 1
mmu-miR-147 0.031 2 exon mir-147
mmu-miR-504 0.018 X intron mir-504
rno-miR-743b 0.005 X intergenic mir-743 3
mmu-miR-470 0.005 X intergenic mir-743 1
mmu-miR-409-3p 0.011 12 exon mir-154 13
mmu-miR-92a 0.027 14,X exon, intergenic mir-25 5
mmu-miR-17 0.039 14 exon mir-17 5
mmu-miR-18a 0.008 14 exon mir-17 5
mmu-miR-670 0.039 2 intron, exon mir-670
mmu-miR-367 0.011 3 intron mir-367 4
rno-miR-760-5p 0.023 2 intergenic mir-760
mmu-miR-325 0.025 X intron mir-325
mmu-miR-220 0.006 * * *
mmu-miR-351 0.039 X intergenic mir-351 6
mmu-miR-200c 0.003 6 intron mir-8 1
mmu-miR-484 0.019 16 Intergenic mir-484
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Table 1 miRNAs that changed significantly with sex and gestation (Continued)
mmu-miR-24 0.007 13,8 intron, exon mir-24 3
mmu-miR-126-3p 0.04 2 intron, exon mir-126
mmu-miR-26a 0.008 9, 10 intron mir-26 1
mmu-miR-30e 0.015 4 intron mir-30 2
mmu-miR-322 0.002 X intergenic mir-322 6
mmu-miR-146a 0.001 11 intergenic mir-146
mmu-miR-150 1x10-3 7 intergenic mir-150 1
mmu-miR-34b-3p 1x10-3 9 intergenic mir-34 1
mmu-miR-29a 0.027 6 intergenic mir-29 1
mmu-miR-30d 1x10-3 15 exon mir-30 1
mmu-miR-146b 0.017 19 intron mir-146
mmu-miR-27a 0.017 8 intergenic mir-27 3
mmu-miR-30a 1x10-3 1 intergenic mir-30
mmu-miR-139-3p 0.005 7 intron mir-139
mmu-miR-615-3p 0.002 15 intron mir-615
rno-miR-327 0.004 * * mir-327
mmu-miR-742 0.003 X intergenic mir-742 4
mmu-miR-486 0.007 8 intron mir-486 1
mmu-miR-340-5p 0.049 11 intron mir-340
mmu-miR-449a 0.025 13 intron mir-449 2
miRNAs that changed significantly with sex and gestation are listed, along with their p-value, chromosome number, the region in which they are located, the
miRNA family they belong to, and the number of miRNAs located within the cluster.
*Information not available.
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fied those miRNAs that changed significantly with ges-
tation or with sex (p<0.05, FDR<33%). This analysis
identified 37 miRNAs that significantly changed with
advancing gestation and 25 miRNAs that were signifi-
cantly different between males and female fetuses. A
group of 13 miRNAs changed significantly with sex and
gestation (interactive effect, Additional file 2). The ma-
jority of the 13 miRNAs with an interactive effect were
also significant by either gestation or sex. The miRNAs
that changed significantly with gestation and sex are
listed in Table 1, along with their p-values, chromo-
somal locations, the miRNA family, and miRNA cluster
that shows the number of other miRNAs located within
the neighboring 10 kb chromosomal region. Fold change
values are listed in Additional file 3.
Networks for miRNAs changing significantly with sex
The cluster dendrogram for miRNAs that changed sig-
nificantly between the development of male and female
lungs is shown in Figure 1. Sex hormones have been
shown to regulate lung development. Androgens, in par-
ticular, have inhibitory effects on lung maturational
events during the gestational interval studied [20-23].
Some of the identified miRNAs have similar gestational
trends between males and females, but the absolutelevels of miRNAs differed greatly between the sexes
(Additional file 1, Additional file 3). In order to decifer
the known functions of the sex-regulated miRNAs, In-
genuity Pathway Analysis software was used to generate
molecular pathways based on known targets of the re-
spective miRNAs. IPA identified two different yet related
networks for those miRNAs significantly different in
developing lung by sex, based on previously validated
targets in the literature (Figure 2). The first network
converged upon several central molecules, only some of
which have been studied in the context of lung develop-
ment. The central convergent molecules include retinoin,
IGF1R, Akt and Tp53.
Retinoic acid, a metabolite of retinoin, promotes lung
maturation and inhibits androgen receptor levels and
function in several organs [24-27]. Further, testosterone
has been shown to modulate retinoic acid activity in the
lacrimal gland [28]. miR-296-3p, miR-125a-5p, miR-342
and miR-486 have all been shown to be regulated by ret-
inoic acid (Figure 2; Additional file 4). IGF signaling has
also been shown to positively influence lung maturation
and vascularization, processes that are negatively regulated
by androgens [29]. Futhermore, IGF1R may facitilate
signaling of other growth factors known to affect fetal
lung maturation in a sex-specific fashion, such as EGFR
[12,30]. miR-182 can regulate IGF1R expression (Figure 2;
Figure 1 Expression patterns of miRNAs that changed significantly with sex between E15 – E18 male and female lungs. Total RNA was
isolated from male and female E15 – E18 whole lungs and miRNA expression profiling was done using Taqman Rodent miRNA real-time PCR
array. Columns with blue bars indicated male lungs, and columns with pink bars indicate female lungs. Each gestational day is normalized to
male E15 time point. Black (0) represents mean value for a gene, green indicates the expression above the mean, and red represents expression
below the mean, as shown in the color key.
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ation and differentiation, processes that play an important
role in late lung development and account for sex differ-
ences. IGF1R total protein levels increase dramatically be-
tween gestational day 16.5 and 17.5, right at the onset of
surfactant synthesis [31,32]. Given our miRNA data, spe-
cific miRNAs can be linked with sex-specific changes in
retinoic acid, androgen control and IGF signaling over an
interval in lung development in which male infants are
known to have a clinical disadvantage in disease related to
delayed lung maturation.
Akt plays several important roles in development
through control of cell proliferation, migration, apoptosis
and transcription. Many of the differentially expressed
miRNAs are involved in cellular responses to amino acid,
growth factor, and hormonal stimuli based on GO Anno-
tations of these miRNAs (Additional file 4). Several signal-
ing molecules and receptors that are important in lung
maturation, including EGFR, ErbB4, PDGF and insulin,
activate Akt signaling. Of these, only EGFR is known tohave a sex-specific development of expression and func-
tion in fetal lungs during this window of development
[33,34]. Pharmacological manipulations of Akt have also
been shown to affect surfactant synthesis synthesis [35].
Other focal centers in the network include Tp53 and
MAP2K4, both of which are tumor suppressor genes that
are deregulated in lung cancer [36,37]. In particular, miR-
486, miR-24, miR-182, miR-615-3p and miR-125a-5p are
regulated by Tp53 (Figure 2; Additional file 4). Little is
known about the functions of Tp53 and MAP2K4 during
lung development, though it is thought that p53 may be
involved in alveolar epithelial cell differentiation [38].
Networks for miRNAs changing significantly with
gestation
The cluster dendrogram for miRNAs that changed
significanty with gestation is shown in Figure 3. The two
central components of this network, based on previously
established targets as identified by IPA analysis, are me-
diators of glucose metabolism (regulation of d-glucose
Figure 2 Network associated with miRNAs that were significantly different between males and females. IPA was used to generate a
network of molecules that are validated targets of miRNAs shown in Figure 1. This network converges on retinoin, IGFR1, Akt and p53. Solid lines
indicate known relationships. Dashed lines indicate proposed relationships.
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thelial growth factor A (VegfA) (Figure 4). Insulin binding
to the insulin receptor (IR) regulates glucose uptake and
metabolism, which is required to produce substrate for
surfactant phospholipid synthesis [39]. The IR, which is
mainly expressed in the alveolar Type II cells, is develop-
mentally regulated in its expression [39,40]. Several of
these differentially expressed miRNAs are associated with
the insulin pathway. These include miR-24, miR-30e, miR-
351, miR-26a and miR-27a (Figure 4; Additional file 4).
VEGFA helps coordinate lung epithelial and endothe-
lial maturation. It is produced and secreted in late gestion
lung by the alveolar epithelium and acts by binding to re-
ceptors on the vascular endothelium in the adjacent mes-
enchyme [41]. As the lung progresses from the canalicular
to saccular stage of development, VEGF levels increase as
the alveolar sacs form and an air-blood interface becomes
established. Further, several studies have shown that
VEGFA mRNA expression increases towards the end of
gestation [3,42]. As shown by transgenic and knockout
models, VEGFA levels are tightly regulated during lung
development. Both increased and decreased expression of
this factor is severely detrimental to vascular development,
including lung vascular development, where it impacts
saccular, alveolar and microvasculature development
within the alveolar unit [43-45]. miR-126, in particular, en-
hances the proangiogenic effects of VEGF and FGF, bytargeting SPRED1 [46]. Several other miRNAs, such as
miR-150, miR-504 and miR-322 have all been shown to
regulate VEGFA expression (Figure 4).
Several other molecules with potential significance for
lung development were also identified by the IPA analysis.
These include fibronectin 1, Src, regulators of neurotrans-
mitter function (NAPG, SLC38A1), regulators of protein
synthesis and processing (GLANT7, SPRP), and those that
control mitochondrial function (COX6Af2, ATPSG2). Of
these, fibronectin has been most studied in lung develop-
ment. Its expression is temporally regulated and helps to
stabilize newly formed airways [47,48].
Discussion
The importance of miRNA control of gene expression
through regulation of mRNA translation during fetal
organ development is becoming increasingly recognized.
MiRNAs regulate specific elements of cardiac morpho-
genesis, brain development, and hematologic develop-
ment [49-51].
Previous profiles of miRNA expression in lungs have
been published [3-7]. Overall, such studies have analyzed
single time points across a wide span of the different
stages of development and maturation. Our study adds
to that information by providing a focused analysis of a
specific window of development, specifically the progres-
sion from late pseudoglandular through the canalicular
Figure 3 Expression patterns of miRNAs that changed significantly with gestational E15 – E18 lungs. Total RNA was isolated from male
and female E15 – E18 whole lungs and miRNA expression profiling was done using Taqman Rodent miRNA real-time PCR array. Columns with
blue bars indicated male lungs, and columns with pink bars indicate female lungs. Each gestational day is normalized to male E15 time point.
Black (0) represents mean value for a gene, green indicates the expression above the mean, and red represents expression below the mean as
shown in the color key.
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This is a crucial developmental period during which the
lung becomes capable of the normal cellular and physio-
logic functions necessary for gas exchange to support life
after birth. Dominant features of this crucial develop-
mental interval are the development of Type II epithelial
cell maturation for surfactant synthesis, the establish-
ment of the microvascular network responsible for effi-
cient gas exchange, and the thinning of the interstitial
mesenchyme to promote an increase in epithelial surface
area for efficient gas exchange. Using data from this
array, we have gone on to study the role of specific
miRNAs in lung airway and vascular development [52].
A major challenge for miRNA studies, whether profiling
the microRNAome or studying an individual miRNA, is
the identification of specific target proteins whose expres-
sion is mediated by specific miRNAs. Several valuable al-
gorithms have been developed which predict miRNA
targets based on the physical chemistry and codonsequences of mRNA molecules [53]. Such algorithms
commonly predict from tens to literally hundreds of po-
tential targets for a given miRNA. Not surprisingly, the
overwhelming majority of such predicted target molecules
remain unvalidated. An additional difficulty is that such
algorithms predict different targets, based on the parame-
ters used to develop the algorithm. A pathway analysis
tool such as IPA is a powerful tool for analyzing inter-
active networks involving multiple miRNA molecules
based on previously established targets. By focusing the
pathway analysis on those miRNAs which changed signifi-
cantly during the interval studied, important clues can be
obtained to direct subsequent focused studies of particular
developmental events in order to identify specific targets.
Our analysis shows that of the large number of com-
mon miRNAs expressed in the mouse, only a relatively
small number show significant developmental or sex-
specific regulation during the interval studied. This sug-
gests that miRNA targets are likely to be focused on
Figure 4 Network associated with miRNAs that were significantly different across gestation. IPA was used to generate a network of
molecules that are validated targets of miRNAs shown in Figure 4. This network converges on IGF, d-glucose and VEGFA. Solid lines indicate
known relationships. Dashed lines indicate proposed relationships.
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Several of the core elements identified by the pathway ana-
lysis substantiate this conclusion. Molecules significant for
vascular development, structural remodeling, cell metabol-
ism, and cell proliferation and differentiation were promin-
ent in the analytical trees. A particular value of the pathway
analysis is that it facilitates identification of specific
miRNAs that have been shown to be involved in these pro-
cesses, making them a good starting point to be studied in
the context of lung development. By focusing on miRNAs
known to participate in specific processes (e.g. miR-126 in
vascular formation), one can begin to tease out their roles
in the developing lung.
The idea that miRNAs have sex dependent expression
patterns is not new. In fact, miRNAs show sex-specificityduring Embryonic Stem (ES) cell differentiation [54]. Male
and female differences in physiology and behavior are
widely recognized as contributors to disparities in health
outcomes. miRNAs are postulated to play an important
role in the sexually dimorphic brain [55]. Sex-based
miRNA differences can also contribute to cardiac patholo-
gies [56,57]. Our data suggest that miRNAs may regulate
sex differences in the lung. The role of androgens in regu-
lating lung sex-specific differences during development
has been well established [13]. In light of this information
it is likely that many of these miRNAs are androgen regu-
lated and further studies would enable identification of an-
drogen regulated miRNA pathways in the lung. However,
it is possible that not all of the sex-specific miRNAs are
regulated by androgens. Other factors, such as estrogen
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specific differences in lung [20].
A few of the miRNAs that were identified as signifi-
cant in our analysis have been studied by other groups.
Transgenic overexpression of the miR17-92 cluster al-
tered proliferation and differentiation of lung progenitor
cells, and Rbl2 was identified as a target of miR17-5p
[58]. A subsequent study showed that the miR-17 family
can target Stat3 and Mapk14 to modulate FGF10-
FGFR2b signaling, which is important in lung epithelial
branching morphogenesis [59]. The miR-302/367 cluster
has been shown to regulate the balance between lung
progenitor cell proliferation and differentiation, as well
as progenitor cell polarity [60].
The results from this study should not be interpreted
to indicate that overall only a few miRNAs are active in
the control of lung development. It is highly probable
that many molecules are under miRNA regulation which
does not change within the interval studied. This is evi-
dent when our results are analyzed within the context of
other studies which evaluated lungs at time points out-
side of the focus of our study. Our work does illustrate
the value of a focused analysis to identify function-
oriented targets of miRNA regulation, based on what is
known about these specific miRNAs.
Conclusions
We have identified a set of miRNAs which exhibit either
developmental or sex-specific expression differences dur-
ing a crucial interval of lung development in preparation
for birth. Pathway analysis identifies convergent inter-
active signaling networks that permit subsequent studies
of focused identification and analysis of miRNA-target re-
lationships, based on previously established targets. This
has significant value in determining the role of miRNAs
for development of the fetal lung.
Additional files
Additional file 1: Figure: miRNA profiling of male and female lungs.
Total RNA was isolated from male and female E15 – E18 whole lungs and
miRNA expression profiling was done using Taqman Rodent miRNA real-
time PCR array. 375 miRNAs were profiled and Ct values were normalized
to U6 snRNA house keeping gene. The technical and biological replicates
were averaged.
Additional file 2: Figure: Expression patterns of miRNAs that
changed significantly with sex and gestation. Total RNA was isolated
from male and female E15 – E18 whole lungs and miRNA expression
profiling was done using Taqman Rodent miRNA real-time PCR array.
Columns with blue bars indicated male lungs, and columns with pink
bars indicate female lungs. Each gestational day is normalized to the
male E15 time point. mmu-miR-363 and mmu-miR-325 are the only
miRNAs that are exclusive to this interaction group. The rest of the
miRNAs in this group overlap with those present in the sex and
gestation groups.
Additional file 3: Table: List of miRNA regulators and targets. Using
the Ingenuity Pathway Analysis database, the GO Annotations, upstreamregulators, and downstream regulators/targets of miRNAs that changed
significantly between sexes and with gestation were identified.
Additional file 4: Fold change values of miRNAs that changed
significantly between sexes and gestation. Fold change values were
calculated using deltaCT values in Additional file 1.
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